Literature DB >> 8067809

In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.

L K Basco1, J Le Bras.   

Abstract

Multidrug-resistant Plasmodium falciparum is widespread in Cambodia. The in vitro susceptibilities of 14 Cambodian isolates to chloroquine, quinine, mefloquine, halofantrine, pyrimethamine, cycloguanil, pyronaridine, artemisinin, arteether, artemether and artelinate were studied using a semi-microtest on day 0 and after 15-30 days of culture. The culture-adapted isolates were all resistant to chloroquine, pyrimethamine and cycloguanil. The susceptibility to quinine was generally low. Three isolates were resistant to mefloquine. A comparison of susceptibility to cycloguanil, quinine, and mefloquine prior to and after culture adaptation showed a trend toward a higher resistance level in some isolates. Halofantrine, pyronaridine and artemisinin derivatives were highly active against the multidrug-resistant Cambodian isolates, with very similar 50% inhibitory concentrations (IC50). These results confirm the presence of multidrug-resistant P. falciparum isolates in Cambodia and indicate that quinine- and mefloquine-resistant populations of the parasite may already exist in the field. The high in vitro activities of halofantrine, pyronaridine and artemisinin derivatives indicate their potential usefulness for the treatment of multidrug-resistant malaria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067809     DOI: 10.1080/00034983.1994.11812851

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  14 in total

1.  Synergistic anti-malarial action of cryptolepine and artemisinins.

Authors:  Arnold D Forkuo; Charles Ansah; Kwesi M Boadu; Johnson N Boampong; Elvis O Ameyaw; Ben A Gyan; Andrea T Arku; Michael F Ofori
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

2.  Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.

Authors:  D J Walker; J L Pitsch; M M Peng; B L Robinson; W Peters; J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

4.  Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.

Authors:  Bruno Pradines; Philippe Hovette; Thierry Fusai; Henri Léonard Atanda; Eric Baret; Philippe Cheval; Joel Mosnier; Alain Callec; Julien Cren; Rémy Amalvict; Jean Pierre Gardair; Christophe Rogier
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.

Authors:  A Brockman; R N Price; M van Vugt; D G Heppner; D Walsh; P Sookto; T Wimonwattrawatee; S Looareesuwan; N J White; F Nosten
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

6.  Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance.

Authors:  Tyler N Bennett; Jigar Patel; Michael T Ferdig; Paul D Roepe
Journal:  Mol Biochem Parasitol       Date:  2007-02-08       Impact factor: 1.759

7.  In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).

Authors:  W Yavo; K B Bla; A J Djaman; S B Assi; L K Basco; A Mazabraud; M Koné
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

8.  In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).

Authors:  Mayfong Mayxay; Marion Barends; Alan Brockman; Anchalee Jaidee; Shalini Nair; Dan Sudimack; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Tim Anderson; Nicholas J White; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

9.  Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.

Authors:  Rithea Leang; Sara E Canavati; Nimol Khim; Lasse S Vestergaard; Isabelle Borghini Fuhrer; Saorin Kim; Mey Bouth Denis; Pisal Heng; Bunkea Tol; Rekol Huy; Stephan Duparc; Arjen M Dondorp; Didier Menard; Pascal Ringwald
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.